| Term 
 | Definition 
 
        | A point in the decision process where the decision-maker must chose from the treatment options available (squares) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A point in the decision process wher ethe events that follow are not in control of the decision-maker (circles) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An exhaustive list of the optoinos (decision nodes) or events (chance nodes) that follow a node (right angles) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | The probabilities associated witht he set of events after each chance node (for each chance node the probabilities must sum to 1) (p,q) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | The assumed set of final outcome "changes" associated with each path through the decision tree that are aligned witht he perspective of the decision-maker (rectangles/terminal nodes) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uncertainty in the patient's diagnosis that may affect the relationship between treatment and outcomes   *Ex:  Treat acute otitis media with ABX? |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uncertainty int he patient's course of disease given a diagnosis that may affect the relationshp between treatment and outcomes   *Ex.  Aggresively treat early stage cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uncertainty in the relationship between treatment and outcome for a given diagnosis and prognosis   *Ex:  Use pharmacologica care with risk of ADR factored into decision tree |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calculate the "expected" consequence following each chance node using respective probabilities as weights   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selecting the decision at each decision node with the best expected outcome and "pruning" all other decision branches |  | 
        |  | 
        
        | Term 
 
        | Clincal Decision Analysis (CDA) |  | Definition 
 
        | A systematic approach to contrast the ability of one or mroe treatment regimens to achieve a single health outcome under uncertainty |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | The activity, set of institutions, and processes for creating, communicating, delivering, and exchanging offerings that have value for customers, clients, partners, and society at large |  | 
        |  | 
        
        | Term 
 
        | Priorities of Marketing (5) |  | Definition 
 
        | 1.  Identify new opportunities 2.  Develop new products 3.  Attract customers 4.  Retain customers and build loyalty 5.  Fulfill orders |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.  Product 2.  Price 3.  Place 4.  Promotion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Group of individuals or organization that have one or mroe similar characteristics, needs, and/or interests |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Narrower segment of population that needs or desires specialized goods/services   *Needs to be sufficient in size, growth potential, not well-served, purchasing potential, demonstrated need |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | The image associated with a company, product, or service   *Integrated marketing communications (IMC) is a key branding strategy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Developing long-term mutually beneficial relatinoship with patients, business partners, and clinical partners |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | How much a pt would pay to improve his/her health state |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | How much a pt would accept as payment to reduce their health state |  | 
        |  | 
        
        | Term 
 
        | Treatment Threshold Price (TTP) |  | Definition 
 
        | The highest price a pt would be willing to pay for a tx given the value of benefits associated with the treatment and the effectiveness of the treatment relative to the alternative outcome. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | The value of the relative advantage of treatment A over treatment B...ie, max pt willing to pay for tx A |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Economic Clinical and Humanistic Outcomes model   *Econ:  opportunity costs, measured by payors and pts *Clnical:  morbidity/mortality; measured by health-care providers *Humanistic:  QOL; measured by pt |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Individual costs, costs to family and friends |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Medical costs and nonmedical (transportation, informal care, etc) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pain, suffering, and greif of pt and anyone who cares |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Costs which vary with the level of service, consumables (labor) |  | 
        |  | 
        
        | Term 
 
        | Cost-Effectiveness Analysis (CEA) ratio |  | Definition 
 
        | CE ratio = (expected cost Tx - expected cost alternative) / (expected health outcome from tx - expected health outcome alternate) |  | 
        |  |